Literature DB >> 828130

Purification and immunochemical characterization of human plasma factor XIII.

M Kazama, J McDonagh, R H Wagner, R D Langdell, R P McDonagh.   

Abstract

A detailed study of the conditions for purification of plasma factor XIII was undertaken and an optimal procedure developed. This procedure involves adsorption with aluminum hydroxide, repeated fractionation with ammonium sulfate, heat denaturation of fibrinogen, precipitation with polyethylene glycol, cryoprecipitation, and chromatography on DEAE-cellulose with gradient elution. The specific activity of the final product, as measured by the fluorescent amine incorporation assay for factor XIII, averages about 3,000-4,000 mumol dansylcadaverine incorporation/mg protein. The yield is about 20%. In SDS electrophoresis the final product has two bands under nonreducing conditions, characteristic of the a and b subunits.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 828130     DOI: 10.1159/000214153

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  4 in total

Review 1.  The human fibrin-stabilizing factors.

Authors:  H Bohn
Journal:  Mol Cell Biochem       Date:  1978-06-28       Impact factor: 3.396

2.  Effects of fibrinogen-binding tetrapeptides on mechanical properties of fine fibrin clots.

Authors:  M D Bale; M F Müller; J D Ferry
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

3.  The presence of gamma' chain impairs fibrin polymerization.

Authors:  Kathryn C Gersh; Chandrasekaran Nagaswami; John W Weisel; Susan T Lord
Journal:  Thromb Res       Date:  2009-01-12       Impact factor: 3.944

4.  Human plasma fibrinogen heterogeneity: evidence for an extended carboxyl-terminal sequence in a normal gamma chain variant (gamma').

Authors:  C Wolfenstein-Todel; M W Mosesson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.